19.6.2024 14:39:45 CEST | Monsenso |
Ændring i ledelse/godkendte rådgivere
Selskabsmeddelelse nr. 15-2024
København den 19. juni 2024
“Denne meddelelse indeholder intern information”
Monsenso skifter Certified Adviser til HC Andersen Capital pr. 1. august 2024.
Skiftet sker blandt andet for at få en bredere rådgivning inden for investor relations. Vi takker i samme forbindelse Norden CEF for samarbejdet siden vores børsintroduktion på Nasdaq First North Growth Market i 2020.
Forespørgsler vedrørende denne meddelelse skal rettes til:
Monsenso
CEOThomas LethenborgTlf. +45 21 29 88 27E-mail: lethenborg@monsenso.com
Certified Adviser
Norden CEF A/SJohn Norden
E-mail: jn@nordencef.dk
Om Monsenso
Monsenso er en innovativ virksomhed, som tilbyder en digital sundhedsløsning til brug for decentaliserede forsøg, patientmonitorering og behandlingsunderstøttelse. Vores mission er at bidrage til bedre sundhed til flere personer og lavere omkostninger ved at understøtte behandling digitalt og bedre udnytte patienters egne data. Vores løsning bidrager til optimering af behandlingen og giver et detaljeret overblik over patienters sundhed via indsamling af data om deres tilstand, adhærens og adfærd. Løsningen forbinder patienter, omsorgspersoner og behandlere for at muliggøre en personligt tilpasset behandling, distancebehandling samt tidlig intervention. Vi samarbejder med sundhedsvæsenet, medicinalindustrien og forskningsinstitutioner verden over i vores forsøg på at levere løsninger som passer ind i patienters og sundhedsprofessionelles hverdag. Få mere at vide på www.monsenso.com
Vedhæftninger
Download selskabsmeddelelse.pdf
19.6.2024 14:39:45 CEST | Monsenso |
Chang. board/management/certified advisors
Company Announcement No. 15-2024
Copenhagen, 2024.06.19
“This message includes inside information”
Monsenso A/S announces change of Certified Adviser to HC Andersen Capital effective August 1, 2024.
The change is being made to obtain broader advice within investor relations, among other areas. We want to extend our gratitude to Norden CEF for serving as our Certified Adviser since the Nasdaq First North Growth Market IPO in 2020.
Any inquiries regarding this notice should be directed to:
Monsenso
CEOThomas LethenborgTel. +45 21 29 88 27E-mail: lethenborg@monsenso.com
Certified Adviser
Norden CEF A/SJohn Norden
E-mail: jn@nordencef.dk
About Monsenso
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence and behavioral data. It connects individuals, carers and health care providers to enable personalised treatment, remote care and early intervention. We collaborate with health and social care, pharmaceuticals and leading researcher worldwide in our endeavors to deliver solutions that fit into the lives of patients and health care professionals. To learn more visit www.monsenso.com
Attachments
Download announcement as PDF.pdf
